I-Mab Biopharma
IMAB
#9317
Rank
โ‚น5.62 B
Marketcap
โ‚น69.07
Share price
-5.65%
Change (1 day)
-53.99%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น0.98 Billion

According to I-Mab Biopharma's latest financial reports the company's total liabilities are โ‚น0.98 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น1.48 B-26.54%
2022-12-31โ‚น2.02 B6.02%
2021-12-31โ‚น1.90 B57.39%
2020-12-31โ‚น1.21 B-77.96%
2019-12-31โ‚น5.50 B11.79%
2018-12-31โ‚น4.92 B147.15%
2017-12-31โ‚น1.99 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น1.03 B 5.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น71.14 B 7,146.22%๐Ÿ‡บ๐Ÿ‡ธ USA